Hodgkin lymphoma remission prolongation: post-ASCT strategies
4 Views
administrator
07/09/23
Anna Sureda, MD, PhD, Catalan Institute of Oncology, Barcelona, Spain, discusses the prolongation of remission with post-autologous stem cell transplant (post-ASCT) strategies in Hodgkin lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
-
Category
Show more
Facebook Comments
No comments found